Mckesson Medical-Surgical Inc. Corporate Office recalls EVENITY and 2…
Mckesson Medical-Surgical Inc. Corporate Office recalls EVENITY and 2 more
- Published
- 30 Jul 2025
- Units affected
- 3 products
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations; potential temperature excursions due to transit delays
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.
BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21
- Brand / company
- Mckesson Medical-Surgical Inc. Corporate Office
- Codes / lots
- Lot: 1178382, Expiration date: 3/31/2027 | Lot: YK4W, Expiration date: 4/30/2029 | Lot: 1180924, Expiration date: 6/30/2027.
- Distribution
- Within the U.S - OH, VA, FL.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.